Evidence map›Paper›PMID 30685826›Full record

ReviewCurrent urology reports2019

Use of Mannitol for Ischemia Reperfusion Injury in Kidney Transplant and Partial Nephrectomies-Review of Literature.

Jose Alejandro Lugo-Baruqui, Rajinikanth Ayyathurai, Adavan Sriram, Kothai Divya Pragatheeshwar

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Current urology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04705402 (A Prospective, Randomized, Double Blinded, Placebo Control Trial to Evaluate Efficacy of Intravenous Mannitol Use During Cadaveric Kidney Transplantation Prior to Kidney Reperfusion), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04705402 naunknown statusnot on this mapstarted 2022, after this paper: background citation

A Prospective, Randomized, Double Blinded, Placebo Control Trial to Evaluate Efficacy of Intravenous Mannitol Use During Cadaveric Kidney Transplantation Prior to Kidney Reperfusion

TypeinterventionalSponsorRabin Medical CenterRan2022 to 2022Enrolled32ConditionsRenal DialysisArmsMannitol, Saline
3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Food sweeteners: Angels or clowns for human health?Current research in food science · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jose Alejandro Lugo-BaruquiHospital Civil de Guadalajara "Fray Antonio Alcalde", Division of Transplant, Department of Surgery, University of Guadalajara, Guadalajara, Mexico. alejandro.lugo.b@gmail.com.
Rajinikanth AyyathuraiDivision of Urology, Northeast Georgia Medical Center, Gainesville, Georgia. uroayya@gmail.com.
Adavan SriramDivision of Urology, Northeast Georgia Medical Center, Gainesville, Georgia.
Kothai Divya PragatheeshwarDepartment of Nephrology, University of Oklahoma, Tulsa, OK, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewFew procedures involve the ischemia-reperfusion injury to organs purposely. Two clear examples in urologic surgery consist on kidney transplantation and partial nephrectomies. RECENT

findingsMannitol is an osmotic diuretic that is commonly used in partial nephrectomies and kidney transplantation to increase renal blood flow and decrease warm-ischemia-related renal injury to preserve estimated glomerular filtration rate (eGFR). We review the current evidence for the use of mannitol and its effects on these procedures.

Indexed as

Diuretics, OsmoticGlomerular Filtration RateHumansKidneyKidney TransplantationMannitolNephrectomyReperfusion InjuryWarm IschemiaDiuretics, OsmoticMannitolIschemia-reperfusion injuryMannitolPartial nephrectomyRenal transplant

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.